Traphaco focuses on modern medicines and invests in EU-GMP factories
April 13, 2024 | 14:51
Vietnam's top herbal pharmaceutical company Traphaco has delivered solid business results for 2023 despite global turbulence, heard the company's AGM on April 12.
Traphaco deepens footprint on green development journey
November 28, 2023 | 15:29
Aside from making premium Oriental medicines, Traphaco has embarked on producing modern pharmaceutical products.
Traphaco: Sustainable development via a green value chain
November 21, 2023 | 09:46
Traphaco aims to establish a green value chain with an extensive distribution system to provide good quality, effective, and safe medicinal products.
Traphaco leverages sustainable values
April 28, 2023 | 08:00
Traphaco has unveiled its new strategy to produce high-class products for traditional and modern medicines, reaffirming the quality of the nation's treatments.
Overseas touch lends to pharma gains
July 29, 2022 | 10:00
Vietnam’s pharma giants are growing with new strategies from foreign leadership, easing local doubts over the possible disappearance of local strong brands.
International investors scoop up major stakes in drugmakers
June 30, 2021 | 14:20
Dealmaking and investment in pharmaceutical and healthcare businesses are increasing in scope as investors are vying for the controlling stake of key players.
Traphaco listed among Vietnam's top Sustainable Companies in 2020
December 14, 2020 | 19:27
Traphaco JSC was honoured with the Top 100 Sustainable Companies of Vietnam in 2020.
Traphaco breaks path for Pharma 4.0 for Vietnam
December 05, 2020 | 11:25
The pharmaceutical sector has very specific characteristics with which all players need to fall in line. Manufacturing relies mainly on machines with stringent hygienic standards across all stages of production.
Traphaco looking steady at threshold into 2021
November 27, 2020 | 09:20
Leading drug maker Traphaco was honoured by the Vietnamese prime minister for the fifth consecutive years at the National Brand Awards on November 25.
Traphaco ahead the revenue and profit curve after nine months
October 26, 2020 | 16:08
Completing nearly 80 per cent of its profit target for the year in just nine months, Traphaco is optimistic of its performance this year.
Ups and downs in pharma industry due to crucial supply chain hiccups
July 14, 2020 | 15:00
After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, and several factors remain that could damage their operational prospects in the months to come.
Big players join hands in national epidemic prevention campaign
February 26, 2020 | 09:00
The threat caused by the novel coronavirus outbreak has been partly relieved with the engagement of leading prestigious players from the pharmaceutical industry, such as Traphaco.
Pharma firms debate reforms
June 05, 2019 | 19:00
With possible new changes in drug rules involving strict conditions for branded pharmaceutical production on the horizon, multinational corporations might find it harder to attend tenders of high-cost branded drugs.
Traphaco sets down on path to circular growth
May 27, 2019 | 08:57
As sustainable growth is gaining ground in future development strategies, Vietnam’s second-largest publicly-traded drug maker Traphaco is focusing on developing a green value chain to optimise its operational efficiency and to protect the environment.
Top pharma groups to rethink strategies after sluggish 2018
May 08, 2019 | 20:00
After a tough 12 months, with Vietnamese pharmaceutical giants continuing to report poor business performance in the first quarter of 2019, new solutions are being sought in order to hold firm amid increasingly mounting competition from international rivals. Bich Thuy reports.
1 2
Mobile Version